Summary
This prediction ended on 18.11.24 with a price of €10.42. With a performance of 85.24% the BUY prediction by TransactionDowntrend30 was a big success. TransactionDowntrend30 has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Evotec SE | -4.205% | -4.205% | -37.470% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by TransactionDowntrend30 for this prediction
In the thread Trading Evotec AG
Die von TransactionDowntrend30 gewählte maximale Laufzeit wurde überschritten